Apomorphine as an alternative to sildenafil in Parkinson's disease

J Neurol Neurosurg Psychiatry. 2002 May;72(5):681. doi: 10.1136/jnnp.72.5.681.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / pharmacology*
  • Apomorphine / administration & dosage
  • Apomorphine / pharmacology*
  • Erectile Dysfunction / drug therapy*
  • Humans
  • Injections, Subcutaneous
  • Male
  • Multiple System Atrophy / complications*
  • Parkinson Disease / complications*
  • Phosphodiesterase Inhibitors / administration & dosage
  • Phosphodiesterase Inhibitors / pharmacology*
  • Piperazines / administration & dosage
  • Piperazines / pharmacology*
  • Purines
  • Sildenafil Citrate
  • Sulfones

Substances

  • Antiparkinson Agents
  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Sildenafil Citrate
  • Apomorphine